Imax
-
Lawyers, Federal Regulators Critical of Malvern-Based Endo’s Royalties from Drug Opana
Lawyers and federal agencies are arguing that Malvern-based drug maker Endo is still profiting from the disgraced oxymorphone pill also known as Opana ER. Back in…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
